SFDA Approves Registration of Pfizer-BioNTech COVID-19 Vaccine

Thursday 1442/4/25 - 2020/12/10
202012/DST_1465445_2187193_7_1_2020121014541820.jpg
  • 202012/DST_1465445_2187193_7_1_2020121014541820.jpg
  • Share on Google+

Riyadh, December 10, 2020, SPA -- The Saudi Food and Drug Authority (SFDA) announced today, Thursday December 10, 2020, that it has approved the registration of Pfizer-BioNTech COVID-19 Vaccine in the Kingdom of Saudi Arabia, after Pfizer submitted a request to approve registering the vaccine, so that health authorities in the Kingdom can then import and use the vaccine.
The decision of the Authority’s approval of registering the vaccine was based on the data provided by Pfizer on November 24, 2020, as soon as the requirements were completed, the Authority began reviewing and evaluating the registration files from several aspects.
Regarding the arrival date of the vaccine and the start of using it, the Authority said that based on the approval issued today, concerned health authorities will start the import procedures according to concerned standards and requirements. The Authority will analyze samples from each incoming vaccine shipment before using it to ensure its quality. The Ministry of Health will announce the date of the vaccine's arrival and the start of using it after completing import requirements.
--SPA
15:10 LOCAL TIME 12:10 GMT
0007